Brief: Thor Medical And Artbio Sign Strategic Long-Term Supply Agreement
Oct 29 (Reuters) - Thor Medical ASA TRMED.OL :
* THOR MEDICAL AND ARTBIO SIGN STRATEGIC LONG-TERM SUPPLY
AGREEMENT FOR THORIUM-228
* AGREEMENT REPRESENTS REVENUES UP TO NOK 400 MILLION
* THORIUM-228 TO BE PRODUCED AT HERØYA INDUSTRIAL PARK
* INVESTMENT DECISION EXPECTED IN Q1 2025, PLANT COMPLETION
IN 12
MONTHS
* SIGNS STRATEGIC SUPPLY AGREEMENT WITH ARTBIO
Source text: ID:nObiFyBcta
Further company coverage: TRMED.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln